Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
XIAOMI-W (01810) founder Lei Jun has increased his stake by 2.6 million shares of the company's Class B ordinary shares.
JINHUI HOLDINGS (00137) Subsidiary plans to sell a ultra-large handy-type vessel.
Shenzhen Hepalink Pharmaceutical Group (09989): Proposed election of Puhong as independent non-executive director.
XIAOMI-W (01810) founder Lei Jun has increased his stake by 2.6 million shares of the company's Class B ordinary shares.
JINHUI HOLDINGS (00137) Subsidiary plans to sell a ultra-large handy-type vessel.
Shenzhen Hepalink Pharmaceutical Group (09989): Proposed election of Puhong as independent non-executive director.
